Capricor Therapeutics, Inc. (CAPR)
35.27
+1.41
(+4.16%)
USD |
NASDAQ |
Apr 24, 16:00
35.05
-0.22
(-0.62%)
After-Hours: 20:00
Capricor Therapeutics Total Assets (Quarterly) : 359.95M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 75.68M |
| Repligen Corp. | 2.950B |
| Vaxart, Inc. | 190.46M |
| Penumbra, Inc. | 1.827B |
| Allogene Therapeutics, Inc. | 415.90M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 54.15M |
| Shareholders Equity (Quarterly) | 305.79M |
| Debt to Equity Ratio | 0.0587 |
| Current Ratio | 9.011 |
| Net Debt Paydown Yield | -0.16% |